Industry Suggests Increase In Spiked Supplements Reflects FDA Investment In Testing, Targeted Selection
This article was originally published in The Tan Sheet
Executive Summary
The number of products marketed as supplements and identified as tainted in 2013 grew 136% from 2011 – the year after FDA announced it would take “swift and strong” enforcement action. Trends in recalls and public notifications likely reflect FDA’s investment in testing products, a strategy in need of updating, supplement industry trade groups say.